# Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)

> **NCT00783146** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 728 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** desloratadine
- **DRUG:** fexofenadine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00783146
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08-01
- **Primary completion:** 2004-10-01
- **Final completion:** 2004-10-01
- **Target enrollment:** 728 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00783146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00783146, "Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00783146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*